EE04055B1 - Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use - Google Patents
Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their useInfo
- Publication number
- EE04055B1 EE04055B1 EEP199900477A EE9900477A EE04055B1 EE 04055 B1 EE04055 B1 EE 04055B1 EE P199900477 A EEP199900477 A EE P199900477A EE 9900477 A EE9900477 A EE 9900477A EE 04055 B1 EE04055 B1 EE 04055B1
- Authority
- EE
- Estonia
- Prior art keywords
- activity
- compositions
- compounds
- treatment
- serine protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83367497A | 1997-04-07 | 1997-04-07 | |
| PCT/US1997/021849 WO1998045275A1 (en) | 1997-04-07 | 1997-12-01 | Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900477A EE9900477A (en) | 2000-06-15 |
| EE04055B1 true EE04055B1 (en) | 2003-06-16 |
Family
ID=25264996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900477A EE04055B1 (en) | 1997-04-07 | 1997-12-01 | Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1019382A1 (en) |
| JP (1) | JP2001519806A (en) |
| KR (1) | KR20010006119A (en) |
| CN (1) | CN1251579A (en) |
| AU (1) | AU752064B2 (en) |
| CA (1) | CA2285454A1 (en) |
| EE (1) | EE04055B1 (en) |
| HU (1) | HUP0001522A3 (en) |
| LT (1) | LT4704B (en) |
| LV (1) | LV12495B (en) |
| NO (1) | NO314183B1 (en) |
| NZ (1) | NZ500029A (en) |
| PL (1) | PL336233A1 (en) |
| SI (1) | SI20115A (en) |
| SK (1) | SK136799A3 (en) |
| WO (1) | WO1998045275A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| WO1999026933A1 (en) * | 1997-11-26 | 1999-06-03 | Axys Pharmaceuticals, Inc. | Substituted amidinoaryl derivatives and their use as anticoagulants |
| WO1999026932A1 (en) * | 1997-11-26 | 1999-06-03 | Axys Pharmaceuticals, Inc. | By amidino group substituted heterocyclic derivatives and their use as anticoagulants |
| GT199900167A (en) * | 1998-10-01 | 2001-03-21 | NEW BIS-BENZIMIDAZOLES. | |
| WO2000020400A1 (en) * | 1998-10-05 | 2000-04-13 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating hepatitis c infections |
| US6541486B1 (en) * | 1999-06-04 | 2003-04-01 | Elan Pharma International Ltd. | Bis-benzimidazole compounds and analogs thereof for inhibiting cell death |
| DE19953899A1 (en) * | 1999-11-10 | 2001-05-17 | Boehringer Ingelheim Pharma | Carboxamide-substituted benzimidazole derivatives, process for their preparation and their use as medicaments |
| WO2001052883A1 (en) * | 2000-01-20 | 2001-07-26 | Amgen Inc. | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US6448281B1 (en) * | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| DE10048715A1 (en) * | 2000-09-30 | 2004-05-19 | Grünenthal GmbH | Use of amino acid for the treatment of pain |
| JP4176477B2 (en) * | 2001-03-01 | 2008-11-05 | 塩野義製薬株式会社 | Nitrogen-containing aromatic heterocyclic derivatives having HIV integrase inhibitory activity |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| DE102011111991A1 (en) | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | New cyclosporin derivatives |
| AP2014007662A0 (en) * | 2011-11-29 | 2014-05-31 | Perosphere Inc | Anticoagulant reversal agents |
| WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
| JP7318009B2 (en) * | 2019-05-21 | 2023-07-31 | 浙江海正薬業股▲ふん▼有限公司 | Macrolide derivative, production method and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105837A (en) * | 1961-10-20 | 1963-10-01 | Upjohn Co | 2, 2'-alkylenebisbenzimidazoles |
| US3210370A (en) * | 1964-06-22 | 1965-10-05 | Upjohn Co | Process for preparing 2, 2'-methylene-bisareneimiazoles |
| JPH09506335A (en) * | 1993-09-22 | 1997-06-24 | ザ、ウェルカム、ファンデーション、リミテッド | Bis (aminobenzimidazolyl) alkanes as antiviral agents |
| US6815461B1 (en) * | 1994-01-20 | 2004-11-09 | The University Of North Carolina At Chapel Hill | Method of inhibiting retroviral integrase |
| US5693515A (en) * | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
-
1997
- 1997-12-01 CA CA002285454A patent/CA2285454A1/en not_active Abandoned
- 1997-12-01 SK SK1367-99A patent/SK136799A3/en unknown
- 1997-12-01 HU HU0001522A patent/HUP0001522A3/en unknown
- 1997-12-01 JP JP54273998A patent/JP2001519806A/en active Pending
- 1997-12-01 EP EP97954520A patent/EP1019382A1/en not_active Withdrawn
- 1997-12-01 KR KR1019997009197A patent/KR20010006119A/en not_active Application Discontinuation
- 1997-12-01 CN CN97182098A patent/CN1251579A/en active Pending
- 1997-12-01 AU AU58950/98A patent/AU752064B2/en not_active Ceased
- 1997-12-01 NZ NZ500029A patent/NZ500029A/en unknown
- 1997-12-01 EE EEP199900477A patent/EE04055B1/en not_active IP Right Cessation
- 1997-12-01 PL PL97336233A patent/PL336233A1/en unknown
- 1997-12-01 SI SI9720094A patent/SI20115A/en unknown
- 1997-12-01 WO PCT/US1997/021849 patent/WO1998045275A1/en not_active Application Discontinuation
-
1999
- 1999-10-06 NO NO19994858A patent/NO314183B1/en unknown
- 1999-11-02 LV LVP-99-153A patent/LV12495B/en unknown
- 1999-11-05 LT LT99-131A patent/LT4704B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998045275A1 (en) | 1998-10-15 |
| NO994858L (en) | 1999-12-06 |
| AU5895098A (en) | 1998-10-30 |
| NZ500029A (en) | 2001-02-23 |
| HUP0001522A3 (en) | 2001-08-28 |
| AU752064B2 (en) | 2002-09-05 |
| NO314183B1 (en) | 2003-02-10 |
| CN1251579A (en) | 2000-04-26 |
| SI20115A (en) | 2000-06-30 |
| LV12495A (en) | 2000-06-20 |
| CA2285454A1 (en) | 1998-10-15 |
| SK136799A3 (en) | 2000-07-11 |
| HUP0001522A2 (en) | 2001-05-28 |
| JP2001519806A (en) | 2001-10-23 |
| LT4704B (en) | 2000-09-25 |
| NO994858D0 (en) | 1999-10-06 |
| LT99131A (en) | 2000-04-25 |
| EE9900477A (en) | 2000-06-15 |
| EP1019382A1 (en) | 2000-07-19 |
| LV12495B (en) | 2001-01-20 |
| PL336233A1 (en) | 2000-06-19 |
| KR20010006119A (en) | 2001-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9900036A (en) | Novel compounds and compositions for the treatment of diseases associated with tryptase activity | |
| EE04055B1 (en) | Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use | |
| BR9712544B1 (en) | SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME AND ITS USES | |
| ATE417602T1 (en) | AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS | |
| ID22878A (en) | ACTIVE COMPOSITION THERAPY | |
| PT1083889E (en) | TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| DE60023128D1 (en) | PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES | |
| GB9701206D0 (en) | Serine derivatives and their use as therapeutic agents | |
| PL360493A1 (en) | Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus | |
| TR199501137A2 (en) | Therapeutically active ingredients | |
| EE04156B1 (en) | Sulfonamides for the treatment of endothelin-mediated diseases | |
| NO994014L (en) | Arylsulfonamides and analogs thereof and their use in the treatment of neurodegenerative diseases | |
| EE200300214A (en) | Sulfonamides for the treatment of endothelin-mediated diseases | |
| DE69836008D1 (en) | COMPOSITION AND TREATMENT AGENT | |
| ES2194720T3 (en) | ENZYMES FOR THE TREATMENT OF MELLITUS DIABETES TYPE I. | |
| ES2192839T3 (en) | TIMOSINA BETA 4 OXIDADA. | |
| FI964342A0 (en) | Halomethylamides as IL-1beta protease inhibitors | |
| PT900563E (en) | PRODUCTION OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF EDEMA AND VENOUS DISEASES | |
| GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
| DE69913380D1 (en) | COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES | |
| NO20004920D0 (en) | Use of protease inhibitors for the treatment of skin damage | |
| HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases | |
| PT1200447E (en) | OXAZINOCARBAZOLES FOR THE TREATMENT OF DISEASES OF THE SNC | |
| DE69830259D1 (en) | Tissue protection and the use thereof | |
| DE60043648D1 (en) | MEDICAMENTS FOR THE TREATMENT OF PERIODONTAL DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20031201 |